| Abstrakt: |
The HEV group exhibited a significant increase in the anti-apoptotic signaling molecule phospho-BAD (P =.005), a significant decrease in B-cell lymphoma 2 (P =.006) and an increase in the phospho-B-cell lymphoma to B-cell lymphoma 2 ratio (P <.001). Furthermore, the HEV group exhibited increased levels of prosurvival signaling markers including phosphoinositide 3-kinase, phosphor-extracellular signal-regulated kinase 1/2, phospho-forkhead box protein O1, and phospho-protein kinase B to protein kinase B ratio (all P <.05)." Keywords: Angiology; Apoptosis; B-Cell Lymphoma; Cancer; Cellular Physiology; Enzymes and Coenzymes; Health and Medicine; Hematology; Immunoproliferative Disorders; Kinase; Lymphatic Diseases and Conditions; Lymphoma; Lymphoproliferative Disorders; Oncology; Transferases EN Angiology Apoptosis B-Cell Lymphoma Cancer Cellular Physiology Enzymes and Coenzymes Health and Medicine Hematology Immunoproliferative Disorders Kinase Lymphatic Diseases and Conditions Lymphoma Lymphoproliferative Disorders Oncology Transferases 124 124 1 10/09/23 20231010 NES 231010 2023 OCT 9 (NewsRx) -- By a News Reporter-Staff News Editor at Heart Disease Weekly -- Investigators discuss new findings in B-cell lymphoma. [Extracted from the article] |
